
7.90 Delayed Data As of May 27 | ![]() Today’s Change | 5.10 Today|||52-Week Range 42.76 | -48.20% Year-to-Date |
The 1 analysts offering 12-month price forecasts for Diffusion Pharmaceuticals Inc have a median target of 100.00, with a high estimate of 100.00 and a low estimate of 100.00. The median estimate represents a +1,165.82% increase from the last price of 7.90.
The current consensus among 1 polled investment analysts is to Hold stock in Diffusion Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.